Malaria Minute, 5 June 2020
Artefenomel is assessed against Plasmodium vivax infection in humans to determine the minimum effective dose required for parasite clearance and a beta version of the Global Vector Hub is launched.
Tags:
Malaria Minute, 5 June 2020
Artefenomel is assessed against Plasmodium vivax infection in humans to determine the minimum effective dose required for parasite clearance and a beta version of the Global Vector Hub is launched.